TrialJournal of gastroenterology2019

The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.

Manuele Furnari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.